SOPHiA GENETICS S.A. (SOPH) Earnings History
Annual and quarterly earnings data from 2019 to 2025
Loading earnings history...
SOPH EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
SOPH Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2025 | 61.9% | -91.8% | -102.2% |
| 2024 | 67.4% | -102.1% | -95.9% |
| 2023 | 68.8% | -120.0% | -126.6% |
| 2022 | 65.7% | -184.7% | -183.9% |
| 2021 | 62.4% | -176.7% | -182.1% |
Download Data
Export SOPH earnings history in CSV or JSON format
Free sign-in required to download data
SOPHiA GENETICS S.A. (SOPH) Earnings Overview
As of May 8, 2026, SOPHiA GENETICS S.A. (SOPH) reported trailing twelve-month net income of -$81M, reflecting -23.2% year-over-year growth. The company earned $-1.14 per diluted share over the past four quarters, with a net profit margin of -102.2%.
Looking at the long-term picture, SOPH's historical earnings data spans multiple years. The company achieved its highest annual net income of -$34M in fiscal 2019.
SOPHiA GENETICS S.A. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including NTRA (-$208M net income, -9.0% margin), EXAS (-$208M net income, -6.4% margin), VCYT ($88M net income, 12.8% margin), SOPH has room to improve margins relative to the peer group. Compare SOPH vs NTRA →
SOPH Earnings vs Peers
Earnings metrics vs comparable public companies
SOPH Historical Earnings Data (2019–2025)
7 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | -$79M | -26.4% | -$71M | $-1.17 | -102.2% | -91.8% |
| 2024 | -$62M | +20.9% | -$67M | $-0.95 | -95.9% | -102.1% |
| 2023 | -$79M | +9.7% | -$75M | $-1.22 | -126.6% | -120.0% |
| 2022 | -$87M | -18.7% | -$88M | $-1.36 | -183.9% | -184.7% |
| 2021 | -$74M | -87.3% | -$71M | $-1.33 | -182.1% | -176.7% |
| 2020 | -$39M | -16.4% | -$37M | $-0.82 | -138.5% | -131.6% |
| 2019 | -$34M | - | -$32M | $-0.53 | -133.2% | -127.3% |
See SOPH's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs SOPH Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare SOPH vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonSOPH — Frequently Asked Questions
Quick answers to the most common questions about buying SOPH stock.
Is SOPH growing earnings?
SOPH EPS fell to $-1.14, with earnings declining -23.2%. This contrasts with the 5-year CAGR of N/A. TTM net income dropped to $-81M.
What are SOPH's profit margins?
SOPHiA GENETICS S.A. net margin is -102.2%, with operating margin at -91.8%. Below-average margins reflect competitive or cost pressures.
How consistent are SOPH's earnings?
SOPH earnings data spans 2019-2025. The declining earnings trend is -23.2% YoY. Historical data enables comparison across business cycles.